Viatris executive charged in insider trading scheme that allegedly netted $7.2 million
Fierce Pharma
NOVEMBER 11, 2022
Viatris executive charged in insider trading scheme that allegedly netted $7.2 million. kdunleavy. Fri, 11/11/2022 - 11:30.
Fierce Pharma
NOVEMBER 11, 2022
Viatris executive charged in insider trading scheme that allegedly netted $7.2 million. kdunleavy. Fri, 11/11/2022 - 11:30.
Medgadget
NOVEMBER 11, 2022
Researchers at the University of Texas at Arlington, in collaboration with Shani Biotechnologies, a local firm, have created a point-of-care device that can accurately measure hemoglobin levels and perform pulse oximetry in individuals with dark skin. At present, methods to determine hemoglobin levels at the point of care, such as pulse oximetry, are inaccurate in individuals with higher levels of melanin in their skin, and there is a clear need to develop alternatives that work for everyone.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Fierce Pharma
NOVEMBER 11, 2022
AstraZeneca poised to lock horns with Merck, BMS and more as Imjudo-Imfinzi combo snags lung cancer approval. fkansteiner. Fri, 11/11/2022 - 09:02.
PharmaVoice
NOVEMBER 11, 2022
Recorded just weeks before his passing, our sit-down interview with the legendary medical sciences entrepreneur showcased his passion for pushing the industry toward its next frontier.
Advertisement
When selecting a clinical supply provider, consideration often focuses upon the manufacturing, packaging, storage and distribution capabilities available that will, at face-value, be sufficient to meet the needs of the sponsor and their trial. However, there are human-based and knowledge-driven factors that are often overlooked that go beyond these basic physical capabilities and are integral to the development and delivery of high performing clinical supply chains.
Fierce Pharma
NOVEMBER 11, 2022
Biogen's incoming CEO Viehbacher gets mixed reviews—and lots of advice—in investor survey. kdunleavy. Fri, 11/11/2022 - 09:37.
Pharmaceutical Technology
NOVEMBER 11, 2022
The European Commission (EC) has granted approval for Sanofi and GSK ’s monovalent, recombinant-protein-based, adjuvanted Covid-19 vaccine, VidPrevtyn Beta, as a booster in adults aged 18 years and above. It is indicated as a booster in people of this age group who were earlier inoculated with a Covid-19 vaccine. The latest development comes after the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) provided a positive opinion on vaccine use.
Pharma Rep Focus brings together the best content for pharma rep professionals from the widest variety of industry thought leaders.
MedCity News
NOVEMBER 11, 2022
Via AI-enabled RPM, healthcare organizations can reduce stress and burnout for nurses and clinical staff, an especially important consideration in a time of widespread healthcare staff shortages that are expected to continue.
Fierce Pharma
NOVEMBER 11, 2022
Leveraging technology to meet HCPs and patients on their own terms. mteefey. Fri, 11/11/2022 - 14:45.
Pharmaceutical Technology
NOVEMBER 11, 2022
AstraZeneca has reported an 11% rise in total revenue to $10.98bn in the third quarter (Q3) 2022 as against $9.87bn in the year-ago quarter. For the quarter ending on 30 September 2022, product sales were reported at $10.59bn from $9.7bn in Q3 last year, indicating a growth of 9%. In the third quarter of 2022, core earnings per share (EPS) were recorded to be $1.67, signifying a 55% increase while reported EPS was $1.06.
Fierce Pharma
NOVEMBER 11, 2022
How PulsePoint is helping pharma marketers reach patients. mteefey. Fri, 11/11/2022 - 15:25.
Advertisement
Clinical trial data management is increasingly challenging as studies grow in complexity. Quickly accessing and analyzing study data is vital for assessing trial progress and patient safety. In this paper, we explore real-time data access and analysis for proactive study management. We investigate using adverse event (AE) data to monitor safety and discuss a clinical analytics platform that supports collaboration and data review workflows.
MedCity News
NOVEMBER 11, 2022
Whether it’s application services for your EMR, service desk support, staffing, or any other host of needs, a managed services partner can take your organization to the next level while providing one thing money can’t buy—peace of mind.
pharmaphorum
NOVEMBER 11, 2022
Elon Musk’s Twitter takeover has been nothing of tumultuous, and that tumult hit home for pharma Thursday when an account impersonating Eli Lilly and Company, taking advantage of lax oversight in the new Twitter Blue program, tweeted “We are excited to announce insulin is free now” Insulin is, of course, not free, especially in the United States where a vial of Humalog, Lilly’s insulin product, can cost upwards of $300 and competing products from Sanofi and Novo Nordisk a
MedCity News
NOVEMBER 11, 2022
When we talk about how building the primary care workforce, we usually focus on physicians. But Greater Good Health is taking a different approach by leveraging nurse practitioners. The company recently launched a leadership program for nurse practitioners to learn clinical and communication skills from one another.
European Pharmaceutical Review
NOVEMBER 11, 2022
Takeda has announced the European Commission’s (EC) authorisation for livtencity TM (maribavir), the first oral UL97 protein kinase inhibitor in adults with post-transplant refractory cytomegalovirus (CMV), who are also resistant to one or more therapies. The drug has been approved for adults who have had haematopoietic stem cell transplants (HSCTs) or solid organ transplants (SOTs) and are resistant to standard antivirals including ganciclovir, valganciclovir, cidofovir and foscarnet.
Advertisement
As the development pipeline for new drugs continues to grow, biopharmaceutical companies are re-evaluating how to best manage and balance resources across an increasing number of development projects and complex clinical trials. There are two approaches that can be used to speed a drug from development to clinic faster: timeline compression and parallel processing, but only one that considers the benefits of integrating clinical supply into the overall drug development process.
pharmaphorum
NOVEMBER 11, 2022
As part of our Women in Pharma series, where we talk to leading figures in the life sciences, we hear from ?eyda Atadan Memi?, recently appointed general manager for Takeda UK and Ireland. Here, she discusses her new role, key steps to a successful career in life sciences, and her plans for the future. What inspired you to pursue a career in the life sciences?
European Pharmaceutical Review
NOVEMBER 11, 2022
A paper, published in the European Journal of Pharmaceutical Sciences identified the quality assurance (QA) challenges and trends of analytical techniques in ocular drug delivery and formulation, focusing on treatments for glaucoma. The paper suggested low bioavailability after topical ophthalmic administration is evidence of the need for more effective molecules, as well as formulations that target sites more precisely.
pharmaphorum
NOVEMBER 11, 2022
A prominent genetics professor at Stanford University in the US has paid $29 million to investors in Nuredis – a biotech that has now been wound up – after a California court found he misrepresented the company to investors. Dr Stanley Cohen was sued by Alafi Capital and the Christopher Alafi Family Trust – the only investors in Nuredis – in 2018. The lawsuit claimed he misled them whist persuading them to invest $20 million in the biotech, set up to develop a candidate therapy for neurodegenera
MedCity News
NOVEMBER 11, 2022
Zenas BioPharma’s Series B financing was the biggest one of the week. Other startups that emerged with new cash include Juvena Therapeutics, Sensorium Therapeutics, and NRG Therapeutics.
Advertisement
Clinical research has entered a new era, one that requires real-time analytics and visualization to allow trial leaders to work collaboratively and to develop, at the click of a mouse, deep insights that enable proactive study management. Learn how Revvity Signals helps drug developers deliver clinical trial data insights in real-time using a fast and flexible data and analytics platform to empower data-driven decision-making.
Medgadget
NOVEMBER 11, 2022
Engineers at MIT have developed a system that could let users of robotic prostheses to more sensitively control their bionic limbs. The technology involves implanting pairs of small magnetic beads into muscles. When the muscles contract, the beads move closer together, allowing prosthetic devices to more precisely calculate a user’s intentions and mirror these.
pharmaphorum
NOVEMBER 11, 2022
The lack of diversity in clinical trials has been a topic of debate for decades, but was thrust into the spotlight as the impact of the pandemic on poorer, less educated and ethnically diverse populations became even more apparent. So has the situation started to improve? Sadly not, says a new report from IQVIA, which looked specifically at the inclusion of Black/African Americans and Hispanics in clinical trials in recent years.
Copyright Clearance Center
NOVEMBER 11, 2022
The post Judge Pan Releases Antitrust Publishing Case Opinion appeared first on Copyright Clearance Center.
PharmaTimes
NOVEMBER 11, 2022
Partnership combines Xbrane’s protein-expression system with Stada’s management teams
Advertisement
The global landscape of clinical trials is rapidly changing as studies become more complex. An increasing number of sponsors are seeking enhanced flexibility in their supply chains to address a variety of clinical supply challenges, including patient demand and reducing delays. Demand-led supply and direct-to-patient distribution are next-generation solutions that are helping to meet these growing needs, allowing for more streamlined processes and patient-centric studies.
MedCity News
NOVEMBER 11, 2022
Check out new developments from Opala, Wheel, GoodRx, Fathom, Tivic Health, and more.
PharmaTimes
NOVEMBER 11, 2022
Facility also includes a cell culture suite, quality control laboratories and technology labs
pharmaphorum
NOVEMBER 11, 2022
Panel. Mark Doyle, Founder of the Method and A Life in a Day. Susan Hendrich, Learning Director, Respiratory, Immunology & Infectious Disease, AstraZeneca. Emma Sutcliffe, Global Patient Officer, Ipsen. Jonah Comstock, Editor-in-Chief, pharmaphorum. The post Measuring the intangible – what is the true value of a “patient centric” initiative appeared first on.
Contrarian Sales Techniques
NOVEMBER 11, 2022
In Who Dares Sells, Patrick Ellis shares the most effective strategies and techniques that can help you achieve success in sales. He also reveals the secrets of his success. The goal of this book is to provide a comprehensive analysis of the psychology of sales success, including the various techniques and principles that are used to achieve this. It shows the reader how these are used to achieve success.
Advertisement
Clinical development organizations face a wide array of challenges when it comes to data, many of which can impact the operational effectiveness of their clinical trials. In this whitepaper, experts from Revvity Signals explore how solutions like TIBCO® Spotfire® enable better, more streamlined studies. The whitepaper also features a success story from Ambrx, a leading biopharmaceutical company, detailing how it has leveraged Spotfire to tackle data quality and collaboration challenges in clinic
Pharmaceutical Technology
NOVEMBER 11, 2022
Investment in AI-based research and development, and a focus on the major diseases that affect people in Africa could facilitate the domestic pharmaceutical industry’s growth and reduce the dependence on imports, experts said at a recent event. Earlier this week, in a panel on “Pharma in Africa” at the Financial Times Global Pharma and Biotech Summit, various stakeholders delved into ways to advance the pharmaceutical industry on the continent.
pharmaphorum
NOVEMBER 11, 2022
Within the pharma industry, patient journey mapping tends to begin with a focus on an identified commercial opportunity. Multiple data sources are then integrated to map the patient journey and pinpoint needs that align with the identified opportunity. However, when patient journeys rely heavily on HCP feedback or big data sources as the backbone, patient-reported experience gets undervalued—and potential opportunities are missed.
Pharmaceutical Commerce
NOVEMBER 11, 2022
Ways the sector has grown over the years, and how it will continue to adapt in the future.
pharmaphorum
NOVEMBER 11, 2022
Our CEO & Founder, Roberto Ascione , has been invited to close Day 2 of the virtual AHIMA22 Global Conference as a keynote speaker, November 11, 2022. Aligning with AHIMA22’s theme of “ The Future of Health Data “, Roberto’s keynote at the end of Day 2 of the conference will focus on themes from his book “ The Future of Health “, providing an insightful and inspirational overview of global digital health trends and the future of health care.
Advertisement
When a CRO is bidding on a project where clinical supplies will be one of the aspects to manage on behalf of the client via a partner, leveraging the expertise of a chosen clinical supply partner can be a valuable resource in demonstrating the CRO’s understanding of and ability to deliver upon critical drug-supply related aspects of the project, and ability to hit key milestones such as FPI for their client.
Let's personalize your content